Under the agreement, scientists at Columbia will use VelocImmune mice to generate antibodies against their research targets and will conduct research to discover potential human therapeutics based on
As part of its patient support program AstraZeneca’s respiratory franchise will utilize WellDoc’s web- and mobile-based asthma solution, including virtual messenger, air quality and pollen count alerts as
This pivotal clinical study evaluated Dyloject in patients with moderate-to-severe postoperative pain following elective orthopedic surgery. A previously completed and successful US pivotal study evaluated Dyloject in patients
Mr Burns will be responsible for the commercialization of Cyntellect’s products and services in the life sciences research market. Mr Burns comes to Cyntellect from GE Healthcare Life
In this letter, the FDA informed Gilead that the review of the company’s new drug application (NDA) has been completed. The agency stated that they cannot approve the
Further, the company announced the senior management team for Abraxis Health, which will focus on biomarkers and personalized medicine. Soon-Shiong will assume the role of chief executive officer,
Barr has also announced that it is the first company to file an abbreviated new drug application with the FDA containing a paragraph IV certification for a generic
This marketing authorization follows the positive opinion issued by the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Evaluation Agency. Teva’s product
Dr Engel brings to Cytochroma over 20 years of experience in regulatory affairs and quality assurance, and will be responsible for directing all of Cytochroma’s regulatory activities, as
The companies plan to work collaboratively with the goal of improving patient outcomes through personalized medicine. Transgenomics’s highly sensitive technologies for DNA mutation detection and analysis are expected
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.